Review of meeting abstracts shows toxicity reporting inconsistent, incomplete

Toxicity reporting in certain abstracts presented in recent years at ASH Annual Meeting and Exposition appeared inconsistent and incomplete, according to a systematic review.
In many cases, toxicity reporting was absent from abstracts, results showed.
Researchers — who reviewed abstracts that highlighted phase 3 clinical trials in acute leukemia presented at ASH from 2017 to 2012 — often observed “formal toxicity minimization” and subjective terms to minimize toxicity.
Healio spoke with Lisa K. Hicks, MD, MSc, associate professor at University of Toronto and hematologist